Row,Date Last Updated,Donating Entity,Donating Country Economic Status,Donated to, Population  ,Receiving Country Economic Status,Receiving Country Continent,Vaccine,License Holder,Mechanism,Donation Date,Donation Amount,Notes,Source,Source
1,6/28/2021,Alrosa Group,,Angola," 31,825,295 ",Lower middle income,Africa,Gamaleya Research Institute_Sputnik V,,Multilateral,6/1/2021,"50,000",,Source ,
1,6/28/2021,Alrosa Group,,Zimbabwe," 14,645,468 ",Lower middle income,Africa,Gamaleya Research Institute_Sputnik V,,Multilateral,6/10/2021,"50,000",,Source ,
2,6/30/2021,Association of Healthcare Providers,,India," 1,366,417,754 ",Lower middle income,Asia,Janssen (J&J)_Ad26.COV2.S,,Multilateral,6/29/21*,"100,000,000*",Potential ,Source ,
3,10/1/2021,Australia,High income,Unknown ,,Unknown ,Oceania ,Oxford-AstraZeneca _AZD1222,,Unknown ,9/23/2021,"38,902,000",,Source ,
3,9/17/2021,Australia,High income,Timor-Leste," 1,293,119 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,AZ,Bilateral,5/5/2021,"30,000",,Source ,Source
3,7/1/2021,Australia,High income,Unknown ,,Unknown ,Asia ,Oxford-AstraZeneca _AZD1222,,Bilateral ,6/11/2021,"10,000,000",As part of G7 vaccine initiative ,Source ,
3,7/1/2021,Australia,High income,Unknown ,,Unknown ,Oceania,Oxford-AstraZeneca _AZD1222,,Bilateral ,6/11/2021,"10,000,000",As part of G7 vaccine initiative ,Source ,
3,6/28/2021,Australia,High income,Fiji," 889,953 ",Upper middle income,Oceania,Oxford-AstraZeneca _AZD1222,AZ,Bilateral,,"1,000,000",,Source ,
3,6/28/2021,Australia,High income,Solomon Islands," 669,823 ",Lower middle income,Oceania,Oxford-AstraZeneca _AZD1222,AZ,Bilateral,,"60,000",,Source ,
3,6/22/2021,Australia,High income,Papua New Guinea," 8,776,109 ",Lower middle income,Oceania,Oxford-AstraZeneca _AZD1222,AZ,Bilateral,3/30/2021,"8,000",,Source ,
4,9/27/2021,Austria ,High income,Unknown ,Unknown ,Unknown ,Unknown ,Unknown ,Unknown ,Unknown ,6/18/2021,"1,000,000",for Western Balkans ,Source ,
5,9/17/2021,Azerbaijan,Upper middle income,Kyrgyzstan," 6,456,900 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,,Bilateral ,7/15/2021,"40,000",,Source ,
5,8/5/2021,Azerbaijan,Upper middle income,Bosnia," 3,301,000 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,SK Bioscience,Bilateral ,7/18/2021,"40,000",,Source ,
5,8/5/2021,Azerbaijan,Upper middle income,Tajikistan," 33,580,650 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,SK Bioscience,Bilateral ,7/18/2021,"40,000",,Source ,
5,8/5/2021,Azerbaijan,Upper middle income,Uzbekistan," 33,580,650 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,SK Bioscience,Bilateral ,7/16/2021,"50,000",,Source ,
6,6/24/2021,Barbados,High income,Suriname ," 581,372 ",Upper middle income,South and Central America,Oxford-AstraZeneca _AZD1222,SII ,Bilateral,2/23/2021,"1,000",,Source,
6,6/22/2021,Barbados,High income,Guyana," 782,766 ",Upper middle income,South and Central America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/11/2021,"3,000",,Source ,
7,9/27/2021,Belgium ,High income,COVAX ,Unknown ,Unknown ,Unknown ,Unknown ,,COVAX ,09/052021,"4,000,000",,Source ,
8,6/28/2021,Bermuda,High income,Trinidad & Tobago," 1,394,973 ",High income ,South and Central America,Oxford-AstraZeneca _AZD1222,,Bilateral ,5/24/2021,"9,000",,Source ,
9,6/23/2021,Bharat Biotech,,India," 1,366,417,754 ",Lower middle income,Asia,Bharat Biotech_COVAXIN,,Bilateral,1/12/2021,"1,650,000",,Source ,
10,9/17/2021,Bulgaria,Upper middle income,Bhutan ," 763,092 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,,EU ,7/29/2021,"172,500",,Source ,
10,10/14/2021,Bulgaria,Upper middle income,Bangladesh ," 163,046,161 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,,EU ,7/29/2021,"270,000",,Source ,
11,10/2/2021,Canada,High income,COVAX ,,COVAX/Other Global Entities,COVAX ,Janssen (J&J)_Ad26.COV2.S,,COVAX ,8/12/2021,"10,000,000",,Source ,
11,9/28/2021,Canada,High income,COVAX ,,COVAX/Other Global Entities,COVAX ,Unknown ,,COVAX ,6/13/2021,"13,000,000",,Source ,
11,9/27/2021,Canada,High income,COVAX ,,COVAX/Other Global Entities,COVAX ,Oxford-AstraZeneca _AZD1222,,COVAX ,7/12/2021,"17,700,000",,Source ,
11,9/17/2021,Canada,High income,Unknown ,,Unknown ,Unknown ,Oxford-AstraZeneca _AZD1222,,Bilateral ,9/2/2021,"762,000",,Source ,
12,6/24/2021,Chile,High income,Paraguay ," 7,044,636 ",Upper middle income,South and Central America,Sinovac_Coronavac ,,Bilateral ,3/6/2021,"20,000",,Source,
12,6/23/2021,Chile,High income,Ecuador," 17,373,662 ",Upper middle income,South and Central America,Sinovac_Coronavac ,,Bilateral,3/6/2021,"20,000",,Source ,
13,10/7/2021,China,Upper middle income,Unknown ,,Unknown ,Africa ,,,,,"9,085,000",,Source ,
13,10/7/2021,China,Upper middle income,Unknown ,,Unknown ,Asia ,,,,,"17,037,000",,Source ,
13,9/30/2021,China,Upper middle income,Malaysia,"31,949,777",Upper middle income,Asia,Sinovac_Coronavac ,,Bilateral,9/29/2021,"1,000,000",,Source,
13,9/30/2021,China,Upper middle income,Thailand,"69,625,582",Upper middle income,Asia,Sinovac_Coronavac ,,Bilateral,9/30/2021,"1,500,000",,Source,
13,9/30/2021,China,Upper middle income,Vietnam,"96,462,106",Lower middle income,Asia,Sinopharm,,Bilateral,9/24/2021,"3,000,000",,Source,
13,9/27/2021,China,Upper middle income,Unknown ,,Unknown ,Unknown ,Unknown ,,Unknown ,9/22/2021,"21,430,000",,Source ,
13,9/24/2021,China,Upper middle income,Unknown ,,Unknown ,South and Central America,,,,,"730,000",,Source ,
13,9/23/2021,China,Upper middle income,Cambodia," 16,486,542 ",Lower middle income,Asia,Sinovac_Coronavac ,,Bilateral ,9/23/2021,"3,000,000",,Source,
13,9/17/2021,China,Upper middle income,African Union ,,Low income ,Africa ,Sinopharm ,,Bilateral ,8/30/2021,"15,000",,Source ,
13,9/17/2021,China,Upper middle income,Bhutan ," 763,092 ",Lower middle income,Asia ,Sinopharm,,COVAX ,7/13/2021,"50,000",,Source ,
13,9/17/2021,China,Upper middle income,Rwanda ," 12,626,950 ",Low income,Africa ,Sinopharm ,,Bilateral ,8/19/2021,"200,000",,Source ,
13,9/17/2021,China,Upper middle income,Senegal ," 16,296,364 ",Lower middle income,Africa,Sinopharm ,,Bilateral ,5/14/2021,"300,000",,Source ,
13,9/17/2021,China,Upper middle income,Serbia ," 6,944,975 ",Upper middle income,Europe,Sinopharm ,,Bilateral ,5/19/2021,"200,000",,Source ,
13,9/17/2021,China,Upper middle income,Solomon Islands ,669823,Lower middle income,Asia ,Sinopharm ,,Bilateral ,4/13/2021,"50,000",,Source ,
13,9/17/2021,China,Upper middle income,Timor-Leste," 1,293,119 ",Lower middle income,Asia,Sinovac_Coronavac ,,Bilateral ,6/5/2021,"100,000",,Source ,
13,9/16/2021,China,Upper middle income,Brunei," 433,285 ",High income ,Asia,Sinopharm,,Bilateral,4/2/2021,"100,000",,Source ,
13,9/10/2021,China,Upper middle income,COVAX ,,COVAX/Other Global Entities,COVAX ,Unknown ,,COVAX ,2/3/2021,"10,000,000",,Source ,
13,9/10/2021,China,Upper middle income,Cuba ,11333483,Upper middle income,South and Central America,Unknown ,,Bilateral ,9/1/2021,"250,000",,Source ,
13,9/9/2021,China,Upper middle income,Cambodia," 16,486,542 ",Lower middle income,Asia,Sinovac_Coronavac ,,Bilateral ,8/22/2021,"500,000",,Source,
13,9/1/2021,China,Upper middle income,Kiribati," 117,606 ",Lower middle income,Asia,Sinopharm,,Bilateral ,9/1/2021,"90,000",,Source,
13,8/19/2021,China,Upper middle income,Philippines," 108,116,615 ",Lower middle income,Asia,Sinopharm,,Bilateral,8/19/2021,"1,000,000",,Source,
13,8/12/2021,China,Upper middle income,Myanmar," 54,045,420 ",Lower middle income,Asia ,Sinopharm,,Bilateral ,7/22/2021,"2,500,000",,Source,Source
13,8/5/2021,China,Upper middle income,Thailand," 69,625,582 ",Upper middle income,Asia,Sinovac_Coronavac ,,Bilateral,4/30/2021,"1,000,000",,Source,
13,7/28/2021,China,Upper middle income,Sri Lanka," 21,803,000 ",Lower middle income,Asia,Sinopharm,,Bilateral,3/31/2021,"500,000",,Source ,Source
13,7/28/2021,China,Upper middle income,Sri Lanka," 21,803,000 ",Lower middle income,Asia,Sinopharm,,Bilateral,5/26/2021,"600,000",,Source ,Source
13,7/28/2021,China,Upper middle income,Sri Lanka," 21,803,000 ",Lower middle income,Asia,Sinopharm,,Bilateral,7/11/2021,"1,600,000",,Source ,Source
13,7/22/2021,China,Upper middle income,Pakistan," 216,565,318 ",Lower middle income,Asia ,Unknown ,,Bilateral ,4/13/2021,"500,000",,Source ,
13,7/22/2021,China,Upper middle income,Trinidad & Tobago," 1,394,973 ",High income ,South and Central America,Unknown ,,Bilateral ,5/14/2021,"100,000",,Source ,
13,7/21/2021,China,Upper middle income,Nepal," 28,608,710 ",Lower middle income,Asia,Sinopharm,,Bilateral,7/16/2021,"1,600,000",,Source,
13,7/21/2021,China,Upper middle income,Tajikistan," 9,321,018 ",Low income,Europe,Sinovac_Coronavac ,,Bilateral,6/20/2021,"300,000",,Source,
13,7/8/2021,China,Upper middle income,El Salvador,"6,453,553",Lower middle income,North America,Sinovac_Coronavac , ,Bilateral,7/3/2021,"1,500,000", ,Source,Source
13,7/1/2021,China,Upper middle income,Antigua & Barbuda," 97,118 ",High income ,North America,Sinopharm, ,Bilateral,6/30/2021,"20,000", ,Source, 
13,7/1/2021,China,Upper middle income,Namibia," 2,494,530 ",Upper middle income,Africa,Sinopharm,,Bilateral,2/18/2021,"100,000",,Source ,
13,7/1/2021,China,Upper middle income,North Macedonia," 2,083,459 ",Upper middle income,Europe,Sinopharm, ,Bilateral,5/1/2021,"800,000"," Confirmed 200k, 600K is likely donation ",Source , 
13,7/1/2021,China,Upper middle income,North Macedonia," 2,083,459 ",Upper middle income,Europe,Sinovac_Coronavac , ,Bilateral,6/28/2021,"500,000", ,Source, 
13,6/30/2021,China,Upper middle income,Afghanistan," 38,041,754 ",Low income,Asia,Sinopharm,,Bilateral ,6/10/2021,"700,000",,Source ,
13,6/28/2021,China,Upper middle income,Chad," 15,946,876 ",Low income,Africa,Sinopharm,,Bilateral,6/3/2021,"200,000",,Source ,
13,6/28/2021,China,Upper middle income,"Congo, Rep."," 5,380,508 ",Lower middle income,Africa,Sinopharm,,Bilateral,2/5/2021,"100,000",,Source ,
13,6/28/2021,China,Upper middle income,Djibouti," 973,560 ",Lower middle income,Africa,Sinovac_Coronavac ,,Bilateral,3/18/2021,"300,000",,Source ,
13,6/24/2021,China,Upper middle income,Afghanistan," 38,041,754 ",Low income,Asia,Unknown ,,Bilateral,3/1/2021,"400,000",,Source,
13,6/24/2021,China,Upper middle income,Bolivia," 11,513,100 ",Lower middle income,South and Central America,Unknown ,,Bilateral,2/24/2021,"100,000",,Source ,
13,6/24/2021,China,Upper middle income,Cambodia," 16,486,542 ",Lower middle income,Asia,Unknown ,,Bilateral,4/29/2021,"400,000",,Source ,
13,6/24/2021,China,Upper middle income,Equatorial Guinea," 1,355,986 ",Upper middle income,Africa,Unknown ,,Bilateral,2/11/2021,"100,000",,Source ,
13,6/24/2021,China,Upper middle income,Georgia," 3,720,382 ",Upper middle income,Europe,Sinovac_Coronavac ,,Bilateral,4/30/2021,"100,000",,Source ,
13,6/24/2021,China,Upper middle income,Guinea," 12,771,246 ",Low income,Africa,Unknown ,,Bilateral,3/3/2021,"200,000",,Source ,
13,6/24/2021,China,Upper middle income,Guyana," 782,766 ",Upper middle income,South and Central America,Unknown ,,Bilateral ,2/2/2021,"20,000",,Source,
13,6/24/2021,China,Upper middle income,Iran ," 82,913,906 ",Upper middle income,Asia,Unknown ,,Bilateral ,2/28/2021,"250,000",,Source,
13,6/24/2021,China,Upper middle income,Iraq," 39,309,783 ",Upper middle income,Asia,Unknown ,,Bilateral,4/11/2021,"250,000",,Source ,
13,6/24/2021,China,Upper middle income,Malaysia," 31,949,777 ",Upper middle income,Asia,Sinovac_Coronavac ,,Bilateral,6/16/2021,"500,000",,Source,
13,6/24/2021,China,Upper middle income,Myanmar," 54,045,420 ",Lower middle income,Asia,Unknown ,,Bilateral,3/5/2021,"500,000",,Source,
13,6/24/2021,China,Upper middle income,Pakistan," 216,565,318 ",Lower middle income,Asia,Unknown ,,Bilateral,3/17/2021,"1,500,000",,Source,
13,6/24/2021,China,Upper middle income,Pakistan," 216,565,318 ",Lower middle income,Asia,Unknown ,,Bilateral,4/27/2021,"1,500,000",,Source ,
13,6/24/2021,China,Upper middle income,Philippines," 108,116,615 ",Lower middle income,Asia,Sinovac_Coronavac ,,Bilateral,2/11/2021,"600,000",,Source ,
13,6/24/2021,China,Upper middle income,Sierra Leone," 7,813,215 ",Low income,Africa,Unknown ,,Bilateral ,2/25/2021,"200,000",,Source,
13,6/24/2021,China,Upper middle income,Syria," 17,070,135 ",Low income,Asia,Unknown ,,Bilateral,6/24/2021,"150,000",,Source ,
13,6/24/2021,China,Upper middle income,Venezuela," 28,515,829 ",Upper middle income,South and Central America,Unknown ,,Bilateral,3/2/2021,"500,000",,Source,
13,6/24/2021,China,Upper middle income,Vietnam," 96,462,106 ",Lower middle income,Asia,Sinopharm,,Bilateral,6/20/2021,"500,000",,Source,
13,6/23/2021,China,Upper middle income,Bolivia," 11,513,100 ",Lower middle income,South and Central America,Sinopharm,,Bilateral,3/24/2021,"100,000",,Source ,
13,6/23/2021,China,Upper middle income,Bosnia," 3,301,000 ",Upper middle income,Europe,Sinopharm,,Bilateral,4/30/2021,"50,000",,Source ,
13,6/23/2021,China,Upper middle income,Gabon," 2,172,579 ",Upper middle income,Africa,Sinopharm,,Bilateral,3/13/2021,"100,000",,Source ,
13,6/23/2021,China,Upper middle income,Iran," 82,913,906 ",Upper middle income,Asia,Sinopharm,,Bilateral,4/15/2021,"400,000",,Source ,
13,6/23/2021,China,Upper middle income,Togo," 8,082,366 ",Low income,Africa,Sinovac_Coronavac ,,Bilateral,4/26/2021,"200,000",,Source ,
13,6/23/2021,China,Upper middle income,Trinidad & Tobago," 1,394,973 ",High income ,South and Central America,Sinopharm,,Bilateral,5/5/2021,"100,000",,Source ,
13,6/22/2021,China,Upper middle income,Algeria," 43,053,054 ",Lower middle income,Africa,Sinopharm,,Bilateral,2/25/2021,"200,000",,Source ,
13,6/22/2021,China,Upper middle income,Angola," 31,825,295 ",Lower middle income,Africa,Unknown ,,Bilateral,3/30/2021,"200,000",,Source ,
13,6/22/2021,China,Upper middle income,Azerbaijan," 10,023,318 ",Upper middle income,Asia,Unknown ,,Bilateral,4/1/2021,"150,000",,Source ,
13,6/22/2021,China,Upper middle income,Barbados," 287,025 ",High income ,North America,Sinopharm,,Bilateral ,4/1/2021,"30,000",,Source ,
13,6/22/2021,China,Upper middle income,Belarus," 9,466,856 ",Upper middle income,Europe,Unknown ,,Bilateral,3/15/2021,"100,000",,Source ,
13,6/22/2021,China,Upper middle income,Cambodia," 16,486,542 ",Lower middle income,Asia,Sinopharm,,Bilateral ,4/1/2021,"1,300,000",,Source ,
13,6/22/2021,China,Upper middle income,Cambodia," 16,486,542 ",Lower middle income,Asia,Unknown ,,Bilateral,3/26/2021,"3,000",,Source ,
13,6/22/2021,China,Upper middle income,Dominican Republic," 86,790,567 ",Upper middle income,North America,Sinopharm,,Bilateral,3/17/2021,"50,000",,Source ,
13,6/22/2021,China,Upper middle income,Egypt," 100,388,073 ",Lower middle income,Africa,Sinopharm,,Bilateral,3/20/2021,"300,000",,Source ,
13,6/22/2021,China,Upper middle income,Ethiopia," 112,078,730 ",Low income,Africa,Unknown ,,Bilateral,3/31/2021,"300,000",,Source ,
13,6/22/2021,China,Upper middle income,Georgia," 3,720,382 ",Upper middle income,Europe,Sinovac_Coronavac ,,Bilateral,4/3/2021,"100,000",,Source ,
13,6/22/2021,China,Upper middle income,Iraq," 39,309,783 ",Upper middle income,Asia,Unknown ,,Bilateral,2/4/2021,"50,000",,Source ,
13,6/22/2021,China,Upper middle income,Kyrgyzstan," 6,456,900 ",Lower middle income,Asia,Sinopharm,,Bilateral,3/29/2021,"150,000",,Source ,
13,6/22/2021,China,Upper middle income,Laos," 7,169,455 ",Lower middle income,Asia,Sinopharm,,Bilateral,4/2/2021,"800,000",(500K donated by Chinese government & 300K donated by Chinese People's Liberation Army) ,Source ,
13,6/22/2021,China,Upper middle income,Laos," 7,169,455 ",Lower middle income,Asia,Sinopharm,,Bilateral,12/1/2020,"302,000",,Source ,
13,6/22/2021,China,Upper middle income,Lebanon," 6,855,713 ",Upper middle income,Asia,Sinopharm,,Bilateral,3/1/2021,"50,000",,Source ,
13,6/22/2021,China,Upper middle income,Maldives," 530,953 ",Upper middle income,Asia,Sinopharm,,Bilateral,3/25/2021,"200,000",,Source ,
13,6/22/2021,China,Upper middle income,Mauritania," 4,525,696 ",Lower middle income,Africa,Sinopharm,,Bilateral,3/26/2021,"50,000",,Source ,
13,6/22/2021,China,Upper middle income,Mongolia," 3,225,167 ",Lower middle income,Asia,Sinopharm,,Bilateral,2/23/2021,"300,000",,Source ,
13,6/22/2021,China,Upper middle income,Montenegro," 622,137 ",Upper middle income,Europe,Sinopharm,,Bilateral,3/3/2021,"30,000",,Source ,
13,6/22/2021,China,Upper middle income,Nepal," 28,608,710 ",Lower middle income,Asia,Sinopharm,,Bilateral,3/30/2021,"800,000",,Source ,
13,6/22/2021,China,Upper middle income,Niger," 23,310,715 ",Low income,Africa,Sinopharm,,Bilateral,3/21/2021,"400,000",,Source ,
13,6/22/2021,China,Upper middle income,Pakistan," 216,565,318 ",Lower middle income,Asia,Sinopharm,,Bilateral,1/27/2021,"500,000",,Source ,
13,6/22/2021,China,Upper middle income,Palestine," 4,685,306 ",Lower middle income,Asia,Sinopharm,,Bilateral,3/29/2021,"100,000",,Source ,
13,6/22/2021,China,Upper middle income,Philippines," 108,116,615 ",Lower middle income,Asia,Sinovac_Coronavac ,,Bilateral,3/24/2021,"400,000",,Source ,
13,6/22/2021,China,Upper middle income,Sudan," 42,813,238 ",Low income,Africa,Sinopharm,,Bilateral,3/24/2021,"250,000",,Source ,
13,6/22/2021,China,Upper middle income,Syria," 17,070,135 ",Low income,Asia,Sinopharm,,Bilateral,2/4/2021,"150,000",,Source ,
13,6/22/2021,China,Upper middle income,Tunisia," 11,694,719 ",Lower middle income,Africa,Sinovac_Coronavac ,,Bilateral,3/28/2021,"100,000",,Source ,Source
13,6/22/2021,China,Upper middle income,Zimbabwe," 14,645,468 ",Lower middle income,Africa,Sinopharm,,Bilateral,3/24/2021,"400,000",,Source ,
13,6/17/2021,China,Upper middle income,Nepal," 28,608,710 ",Lower middle income,Asia,Sinopharm,,Bilateral,6/8/2021,"1,000,000",, Source ,
13,6/17/2021,China,Upper middle income,Pakistan," 216,565,318 ",Lower middle income,Asia,CanSino Biologics_Ad5-nCoV,,Bilateral,4/30/2021,"500,000",,Source,
13,6/16/2021,China,Upper middle income,Bangladesh," 163,046,161 ",Lower middle income,Asia,Unknown ,,Bilateral,4/22/2021,"600,000",,Source ,
13,6/16/2021,China,Upper middle income,Benin," 11,801,151 ",Lower middle income,Africa,Sinovac_Coronavac ,,Bilateral,3/22/2021,"100,000",,Source ,
13,6/16/2021,China,Upper middle income,Bolivia," 11,513,100 ",Lower middle income,South and Central America,Sinopharm,,Bilateral,2/11/2021,"100,000",,Source ,
13,6/16/2021,China,Upper middle income,Botswana," 2,303,697 ",Upper middle income,Africa,Sinovac_Coronavac ,,Bilateral,4/26/2021," 200,000 ",,Source ,
13,6/16/2021,China,Upper middle income,Cambodia," 16,486,542 ",Lower middle income,Asia,Sinopharm,,Bilateral,5/24/2021," 1,700,000 ",,Source ,
13,6/16/2021,China,Upper middle income,Cameroon," 25,876,380 ",Lower middle income,Africa,Sinopharm,,Bilateral,4/14/2021,"200,000",,Source ,
13,6/16/2021,China,Upper middle income,Ecuador," 17,373,662 ",Upper middle income,South and Central America,Sinovac_Coronavac ,,Bilateral,3/6/2021,"20,000",,Source ,
13,6/16/2021,China,Upper middle income,El Salvador," 6,453,553 ",Lower middle income,North America,Sinovac_Coronavac ,,Bilateral,4/4/2021,"150,000",,Source ,
13,6/16/2021,China,Upper middle income,Guinea," 12,771,246 ",Low income,Africa,Sinopharm,,Bilateral,4/18/2021,"200,000",,Source ,
13,6/16/2021,China,Upper middle income,Guyana," 782,766 ",Upper middle income,South and Central America,Sinopharm,,Bilateral,6/9/2021,"20,000",,Source ,
13,6/16/2021,China,Upper middle income,Iraq," 39,309,783 ",Upper middle income,Asia,Sinopharm,,Bilateral,2/3/2021,"50,000",,Source ,
13,6/16/2021,China,Upper middle income,Maldives," 530,953 ",Upper middle income,Asia,Sinopharm,,Bilateral,3/15/2021,"218,000",,Source ,
13,6/16/2021,China,Upper middle income,Mauritius," 1,265,711 ",High income ,Africa,Sinopharm,,Bilateral,4/14/2021,"100,000",,Source ,
13,6/16/2021,China,Upper middle income,North Macedonia," 2,083,459 ",Upper middle income,Europe,Sinopharm,,Bilateral,5/1/2021,"100,000",,Source ,
13,6/16/2021,China,Upper middle income,Pakistan," 216,565,318 ",Lower middle income,Asia,CanSino Biologics_Ad5-nCoV,,Bilateral,4/14/2021,"1,000,000",,Source ,
13,6/16/2021,China,Upper middle income,Somalia," 15,442,905 ",Low income,Africa,Sinopharm,,Bilateral,4/11/2021,"200,000",,Source ,
13,6/16/2021,China,Upper middle income,Zimbabwe," 14,645,468 ",Lower middle income,Africa,Sinopharm,,Bilateral,2/15/2021,"400,000",,Source ,
14,9/17/2021,Croatia,High income,Bhutan ," 763,092 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,,EU ,7/29/2021,"10,000", Through EU  ,Source ,
15,9/27/2021,Czech Republic ,High income,Unknown ,Unknown ,Unknown ,Unknown ,Unknown ,,EU/COVAX ,7/26/2021,"2,390,000",,Source ,
16,7/2/2021,Denmark,High income,COVAX ,,COVAX/Other Global Entities,COVAX ,Unknown ,,COVAX ,5/25/2021,"6,000,000",,Source ,
17,9/27/2021,Estonia,High income,Unknown ,Unknown ,Unknown ,Unknown ,Unknown ,,COVAX ,6/18/2021,"200,000",,Source ,
17,9/27/2021,Estonia,High income,Unknown ,Unknown ,Unknown ,Unknown ,Unknown ,,Bilateral ,6/18/2021,"500,000",,Source ,
17,9/17/2021,Estonia,High income,Ukraine ," 44,385,155 ",Lower middle income,Europe,Oxford-AstraZeneca _AZD1222,,EU/COVAX ,9/17/2021,"200,000",,Source ,
18,10/7/2021,EU,High income, Bangladesh ,"163,046,161",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,AZ,COVAX,7/8/2021," 1,000,000 ",,Source ,
18,9/27/2021,EU,High income, Unknown ,,Unknown ,Unknown,Unknown ,,,9/15/2021," 133,205,400 ",,Source ,Source 
19,9/27/2021,Finland,High income,Unknown ,Unknown ,Unknown ,Unknown ,Unknown ,,EU/COVAX ,9/9/2021,"3,600,000",,Source ,
20,10/1/2021,France,High income,COVAX , Unknown  , Unknown  , Africa  , Unknown  ,,Unknown ,9/25/2021,"60,000,000",,Source ,
20,9/10/2021,France,High income,Sudan," 42,813,238 ",Low Income,Africa,Oxford-AstraZeneca _AZD1222,AZ,Bilateral ,8/28/2021,"218,400",,Source ,
20,6/28/2021,France,High income,COVAX ,,COVAX/Other Global Entities,COVAX ,Unknown ,,COVAX,6/14/2021,"60,000,000",,Source ,
20,6/23/2021,France,High income,Slovakia," 5,454,073 ",High income ,Europe,Oxford-AstraZeneca _AZD1222,AZ,Bilateral,3/7/2021,"15,000",,Source ,
21,7/12/2021,Germany,High income,Namibia," 2,494,530 ",Upper middle income,Africa,Oxford-AstraZeneca _AZD1222,,Bilateral,7/11/2021,"25,000",,Source ,
21,7/11/2021,Germany,High income,Ukraine," 44,385,155 ",Lower middle income,Europe,Oxford-AstraZeneca _AZD1222,,Bilateral,7/10/2021,"25,000",,Source ,
21,7/10/2021,Germany,High income,Moldova," 2,657,637 ",Upper middle income,Europe,Oxford-AstraZeneca _AZD1222,,Bilateral,7/9/2021,"25,000",,Source ,
21,7/9/2021,Germany,High income,Georgia," 3,720,382 ",Upper middle income,Europe,Oxford-AstraZeneca _AZD1222,,Bilateral,7/8/2021,"25,000",,Source ,
21,6/28/2021,Germany,High income,COVAX ,,COVAX/Other Global Entities,COVAX ,Unknown ,,Bilateral ,5/22/2021,"100,000,000",,Source ,Source 
22,10/14/2021,Greece,High income,Egypt ," 100,388,073 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,,Bilateral ,9/24/2021,"250,000",,Source ,
22,10/14/2021,Greece,High income,Rwanda ," 12,626,950 ",Low income ,Africa,Oxford-AstraZeneca _AZD1222,,Bilateral ,9/3/2021,"200,000",,Source ,
22,9/17/2021,Greece,High income,Kenya ," 52,573,973 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,,Bilateral ,8/7/2021,"180,000",,Source ,
22,9/17/2021,Greece,High income,Libya ," 6,777,452 ",Upper middle income,Africa,Oxford-AstraZeneca _AZD1222,,Bilateral ,8/17/2021,"200,000",,Source ,
23,6/28/2021,Grenada,Upper middle income,Trinidad & Tobago," 1,394,973 ",High income ,South and Central America,Oxford-AstraZeneca _AZD1222,,Bilateral ,5/30/2021,"10,000",,Source ,
24,10/14/2021,Hungary ,High income ,Vietnam ," 96,462,106 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,,Bilateral,9/22/2021,"100,000",,Source ,
25,9/17/2021,India,Lower middle income,Maldives," 530,954 ",Upper middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/1/2021,"100,000",,Source ,
25,6/24/2021,India,Lower middle income,Cote d'Ivoire," 25,716,544 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral ,3/5/2021,"50,000",,Source,
25,6/18/2021,India,Lower middle income,Bangladesh," 163,046,161 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,4/2/2021,"100,000",,Source ,
25,6/17/2021,India,Lower middle income,Bangladesh," 163,046,161 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/26/2021,"1,200,000",,Source ,
25,6/17/2021,India,Lower middle income,Bhutan," 763,092 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/21/2021,"400,000",,Source ,
25,6/17/2021,India,Lower middle income,Jamaica," 2,948,279 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/20/2021,"100,000",,Source ,
25,6/17/2021,India,Lower middle income,Nepal," 28,608,710 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/28/2021,"100,000",,Source ,
25,6/17/2021,India,Lower middle income,Paraguay," 7,044,636 ",Upper middle income,South and Central America,Bharat Biotech_COVAXIN,,Bilateral,4/22/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Afghanistan," 38,041,754 ",Low income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/7/2021,"500,000",,Source ,
25,6/16/2021,India,Lower middle income,Albania," 2,854,191 ",Upper middle income,Europe,Oxford-AstraZeneca _AZD1222,SII,Bilateral,4/16/2021,"50,000",,Source ,
25,6/16/2021,India,Lower middle income,Antigua & Barbuda," 97,118 ",High income ,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/27/2021,"40,000",,Source ,
25,6/16/2021,India,Lower middle income,Bahamas," 389,482 ",High income ,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/10/2010,"20,000",,Source ,
25,6/16/2021,India,Lower middle income,Bahrain," 1,641,172 ",High income ,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/28/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Bangladesh," 163,046,161 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/21/2021,"2,000,000",,Source ,
25,6/16/2021,India,Lower middle income,Barbados," 287,025 ",High income ,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/7/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Belize," 390,353 ",Upper middle income,North America,Bharat Biotech_COVAXIN,,Bilateral,3/7/2021,"25,000",,Source ,
25,6/16/2021,India,Lower middle income,Bhutan," 763,092 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/20/2021,"150,000",,Source ,
25,6/16/2021,India,Lower middle income,Botswana," 2,303,697 ",Upper middle income,Africa,Bharat Biotech_COVAXIN,,Bilateral,3/7/2021,"30,000",,Source ,
25,6/16/2021,India,Lower middle income,Dominica," 71,808 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/7/2021,"70,000",,Source ,
25,6/16/2021,India,Lower middle income,Dominican Republic," 10,738,958 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/18/2021,"30,000",,Source ,
25,6/16/2021,India,Lower middle income,DR Congo," 5,380,508 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/4/2021,"50,000",,Source ,
25,6/16/2021,India,Lower middle income,Eswatini," 1,148,130 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/9/2010,"20,000",,Source ,
25,6/16/2021,India,Lower middle income,Fiji," 889,953 ",Upper middle income,Oceania,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/26/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Ghana," 30,417,856 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/4/2021,"50,000",,Source ,
25,6/16/2021,India,Lower middle income,Guatemala," 16,604,026 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/2/2021,"200,000",,Source ,
25,6/16/2021,India,Lower middle income,Guyana," 782,766 ",Upper middle income,South and Central America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/5/2021,"80,000",,Source ,
25,6/16/2021,India,Lower middle income,Ivory Coast," 25,716,544 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/4/2021,"50,000",,Source ,
25,6/16/2021,India,Lower middle income,Jamaica," 2,948,279 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/9/2021,"50,000",,Source ,
25,6/16/2021,India,Lower middle income,Jamaica," 2,948,279 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/5/2021,"50,000",,Source ,
25,6/16/2021,India,Lower middle income,Kenya," 52,573,973 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/10/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Malawi," 18,628,747 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/12/2021,"50,000",,Source ,
25,6/16/2021,India,Lower middle income,Maldives," 530,953 ",Upper middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/19/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Mauritius," 1,265,711 ",High income ,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/22/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Mongolia," 3,225,167 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/21/2021,"150,000",,Source ,
25,6/16/2021,India,Lower middle income,Mozambique," 30,366,036 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/7/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Myanmar," 54,045,420 ",Lower middle income,Asia,Bharat Biotech_COVAXIN,,Bilateral,2/11/2021,"200,000",,Source ,
25,6/16/2021,India,Lower middle income,Myanmar," 54,045,420 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/22/2021,"1,500,000",,Source ,
25,6/16/2021,India,Lower middle income,Namibia," 2,494,530 ",Upper middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/18/2021,"30,000",,Source ,
25,6/16/2021,India,Lower middle income,Nauru," 12,581 ",High income ,Oceania,Oxford-AstraZeneca _AZD1222,SII,Bilateral,4/6/2021,"10,000",,Source ,
25,6/16/2021,India,Lower middle income,Nepal," 28,608,710 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/21/2021,"1,000,000",,Source ,
25,6/16/2021,India,Lower middle income,Nicaragua," 6,545,502 ",Lower middle income,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/5/2021,"200,000",,Source ,
25,6/16/2021,India,Lower middle income,Niger," 23,310,715 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/28/2021,"25,000",,Source ,
25,6/16/2021,India,Lower middle income,Nigeria," 200,963,599 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/25/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Oman," 4,974,986 ",High income ,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/30/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Paraguay," 7,044,636 ",Upper middle income,South and Central America,Bharat Biotech_COVAXIN,,Bilateral,3/26/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,Rwanda," 12,626,950 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/4/2021,"50,000",,Source ,
25,6/16/2021,India,Lower middle income,Senegal," 16,296,364 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/4/2021,"25,000",,Source ,
25,6/16/2021,India,Lower middle income,Seychelles," 97,625 ",High income ,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/22/2021,"50,000",,Source ,
25,6/16/2021,India,Lower middle income,Sri Lanka," 21,803,000 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,SII,Bilateral,1/28/2021,"500,000",,Source ,
25,6/16/2021,India,Lower middle income,St. Kitts & Nevis," 52,823 ",High income ,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/27/2021,"20,000",,Source ,
25,6/16/2021,India,Lower middle income,St. Lucia," 182,790 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/27/2021,"25,000",,Source ,
25,6/16/2021,India,Lower middle income,St. Vincent & Grenadines," 110,589 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/27/2021,"40,000",,Source ,
25,6/16/2021,India,Lower middle income,Suriname," 581,372 ",Upper middle income,South and Central America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/27/2021,"50,000",,Source ,
25,6/16/2021,India,Lower middle income,Trinidad & Tobago," 1,394,973 ",High income ,South and Central America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,4/9/2021,"40,000",,Source ,
25,6/16/2021,India,Lower middle income,Uganda," 44,269,594 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/7/2021,"100,000",,Source ,
25,6/16/2021,India,Lower middle income,UN Peacekeepers,,COVAX/Other Global Entities,International Organization ,Oxford-AstraZeneca _AZD1222,SII,Bilateral,3/27/2021,"200,000",,Source ,
25,6/16/2021,India,Lower middle income,Zimbabwe," 14,645,468 ",Lower middle income,Africa,Bharat Biotech_COVAXIN,,Bilateral,3/28/2021,"35,000",,Source ,
26,10/7/2021,Ireland,High income,Uganda," 44,269,594 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,AZ,COVAX ,9/28/2021,"335,500",,Source ,
26,9/27/2021,Ireland ,High income,Unknown ,Unknown ,Unknown ,Unknown ,Unknown ,,COVAX ,9/15/2021,"1,000,000",,Source ,
27,9/17/2021,Israel,High income,Czech Republic ," 10,669,709 ",High income ,Europe,Pfizer-BioNTech_BNT162,,Bilateral,2/25/2021,"5,000",,Source,
27,6/24/2021,Israel,High income,Guatemala ," 16,604,026 ",Upper middle income,North America,Moderna_mRNA-1273,,Bilateral,2/24/2021,"5,000",,Source,
27,6/24/2021,Israel,High income,Honduras," 9,746,117 ",Lower middle income,North America,Moderna_mRNA-1273,,Bilateral,2/24/2021,"5,000",,Source,
27,6/24/2021,Israel,High income,West Bank and Gaza," 4,685,306 ",Lower middle income,Asia,Moderna_mRNA-1273,,Bilateral,1/31/2021,"5,000",,Source,
27,6/22/2021,Israel,High income,Syria," 17,070,135 ",Low income,Asia,Gamaleya Research Institute_Sputnik V,,Bilateral,3/17/2021,"5,000",,Source ,
28,10/1/2021,Italy,High income,COVAX ,,COVAX/Other Global Entities,COVAX ,Unknown ,,Bilateral ,5/25/2021,"45,000,000",,Source ,
29,9/27/2021,Japan,High income,COVAX ,,COVAX/Other Global Entities,COVAX ,Unknown ,,COVAX ,9/23/2021,"30,000,000",,Source ,
29,9/17/2021,Japan,High income,Cambodia ," 16,486,542 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,,Bilateral ,7/23/2021,"1,000,000",,Source ,
29,9/17/2021,Japan,High income,Nepal ," 28,608,710 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,,Bilateral ,8/7/2021,"1,600,000",,Source ,
29,9/1/2021,Japan,High income,Bangladesh," 163,046,161 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,AZ,COVAX,8/29/2021,"3,000,000",,Source ,
29,7/1/2021,Japan,High income,COVAX ,,COVAX/Other Global Entities,COVAX ,Unknown ,,COVAX,6/24/2021,"30,000,000",,Source ,
29,6/30/2021,Japan,High income,Indonesia," 270,625,568 ",Upper middle income,Asia,Oxford-AstraZeneca _AZD1222,,Bilateral ,6/25/2021,"1,000,000",,Source ,
29,6/30/2021,Japan,High income,Malaysia," 31,949,777 ",Upper middle income,Asia,Oxford-AstraZeneca _AZD1222,,Bilateral ,6/25/2021,"1,000,000",,Source ,
29,6/30/2021,Japan,High income,Philippines," 108,116,615 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,,Bilateral ,6/25/2021,"1,000,000",,Source ,
29,6/30/2021,Japan,High income,Vietnam," 96,462,106 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,,Bilateral ,6/25/2021,"1,000,000",,Source ,
29,6/28/2021,Japan,High income,Taiwan," 23,839,313 ",High income ,Asia,Oxford-AstraZeneca _AZD1222,,Bilateral ,6/4/2021,"1,240,000",,Source ,
29,6/28/2021,Japan,High income,Thailand," 69,625,582 ",Upper middle income,Asia,Oxford-AstraZeneca _AZD1222,,Bilateral ,6/21/2021,"1,050,000",,Source ,Source
30,10/14/2021,Latvia ,High income,Albania ," 2,854,191 ",Upper middle income,Europe ,Oxford-AstraZeneca _AZD1222,,Bilateral ,8/30/2021,"30,000",,Source ,
30,10/14/2021,Latvia ,High income,Kenya ," 52,573,973 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,,Bilateral ,7/28/2021,"55,200",,Source ,
30,10/14/2021,Latvia ,High income,Tunisia ," 11,694,719 ",Lower middle income,Africa ,Oxford-AstraZeneca _AZD1222,,Bilateral ,7/28/2021,"50,000",,Source ,
30,10/14/2021,Latvia ,High income,Moldova ," 2,657,637 ",Lower middle income,Asia ,Oxford-AstraZeneca _AZD1222,,Bilateral ,10/8/2021,"30,000",,Source,
31,9/17/2021,Lithuania,High income,Armenia ," 2,957,731 ",Upper middle income,Europe ,Oxford-AstraZeneca _AZD1222,,Bilateral ,8/18/2021,"27,500",,Source ,
31,9/3/2021,Lithuania,High income,Taiwan," 23,839,313 ",High income ,Asia ,Oxford-AstraZeneca _AZD1222,,Bilateral ,6/22/2021,"20,000",,Source ,
31,6/28/2021,Lithuania,High income,Georgia," 3,720,382 ",Upper middle income,Europe,Oxford-AstraZeneca _AZD1222,,Bilateral ,5/14/2021,"15,000",,Source ,
31,6/28/2021,Lithuania,High income,Moldova," 2,657,637 ",Lower middle income,Europe,Oxford-AstraZeneca _AZD1222,,Bilateral ,5/14/2021,"11,000",,Source ,
31,6/28/2021,Lithuania,High income,Ukraine," 44,385,155 ",Lower middle income,Europe,Oxford-AstraZeneca _AZD1222,,Bilateral ,5/14/2021,"100,000",,Source ,
32,9/27/2021,Luxembourg ,High income,Unknown ,Unknown ,Unknown ,Unknown ,Unknown ,,EU/COVAX ,6/7/2021,"350,000",,Source ,
33,9/8/2021,Mexico,Upper middle income,El Salvador," 6,453,553 ",Lower middle income,North America,Oxford-AstraZeneca _AZD1222,,Bilateral,6/24/2021,"100,800",,Source ,
33,9/8/2021,Mexico,Upper middle income,Guatemala," 16,604,026 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,,Bilateral,6/24/2021,"150,000",,Source ,
33,6/28/2021,Mexico,Upper middle income,Honduras," 9,746,117 ",Lower middle income,North America,Oxford-AstraZeneca _AZD1222,,Bilateral ,6/18/2021,"154,100",,Source ,
34,10/14/2021,Morocco,Lower middle income ,Mauritius," 1,265,711 ",High income ,Africa ,Sinopharm,,Bilateral ,5/20/2021,"280,000",,Source ,
35,6/22/2021,MTN Group,,Liberia," 4,937,374 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,,"27,000",,Source ,
35,6/22/2021,MTN Group,,Nigeria," 200,963,599 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,3/22/2021,"300,000",,Source ,
35,6/16/2021,MTN Group,,Gambia," 2,347,706 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,3/25/2021,"777,778",,Source ,
35,6/16/2021,MTN Group,,Ghana," 30,417,856 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,3/25/2021,"777,778",,Source ,
35,6/16/2021,MTN Group,,Guinea-Bissau," 12,771,246 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,3/25/2021,"777,778",,Source ,
35,6/16/2021,MTN Group,,Malawi," 18,628,747 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,3/25/2021,"777,778",,Source ,
35,6/16/2021,MTN Group,,Mauritius," 1,265,711 ",High income ,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,3/25/2021,"777,778",,Source ,
35,6/16/2021,MTN Group,,Senegal," 16,296,364 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,3/25/2021,"777,778",,Source ,
35,6/16/2021,MTN Group,,Sierra Leone," 7,813,215 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,3/25/2021,"777,778",,Source ,
35,6/16/2021,MTN Group,,South Sudan," 11,062,113 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,3/25/2021,"777,778",,Source ,
35,6/16/2021,MTN Group,,Togo," 8,082,366 ",Low income,Africa,Oxford-AstraZeneca _AZD1222,SII,Multilateral,3/25/2021,"777,778",,Source ,
36,10/1/2021,Netherlands ,,COVAX , Unknown  , Unknown  , Unknown  , Unknown  ,,COVAX ,9/24/2021,"20,000,000",,Internal/WHO source ,
37,9/27/2021,New Zealand,High income,COVAX ,,Upper middle income,Oceania,Oxford-AstraZeneca _AZD1222,,COVAX ,6/1/2021,"1,600,000",,Source ,
37,6/23/2021,New Zealand,High income,Fiji," 889,953 ",Upper middle income,Oceania,Oxford-AstraZeneca _AZD1222,AZ,Bilateral,4/30/2021,"500,000",,Source ,
38,9/27/2021,Norway,High income,COVAX ,Unknown ,Unknown ,Unknown ,Unknown ,,COVAX,7/30/2021,"5,000,000",,Source ,
39,10/7/2021,Poland,High income,Egypt," 37,970,874 ",Lower middle income,Africa ,Oxford-AstraZeneca _AZD1222,SII,Bilateral ,9/29/2021," 100,000 ",,Source ,
39,9/17/2021,Poland,High income,Vietnam," 96,462,106 ",Lower middle income,Asia,Oxford-AstraZeneca _AZD1222,,Bilateral ,8/23/2021," 500,000 ",,Source ,
39,6/16/2021,Poland,High income,Ukraine," 44,385,155 ",Lower middle income,Europe,Oxford-AstraZeneca _AZD1222,SII,Bilateral,2/10/2021," 1,200,000 ",,Source,
40,9/27/2021,Portugal,High income,COVAX ,Unknown ,COVAX/Other Global Entities,COVAX ,Unknown ,,COVAX ,7/17/2021,"2,999,998",For Portuguese speaking countries ,Source ,
40,7/1/2021,Portugal,High income,Angola," 31,825,295 ",Lower middle income,Africa ,Unknown ,,Bilateral ,2/24/2021,"162,667",Part of the 1M donation ,Source ,
40,7/1/2021,Portugal,High income,East Timor," 1,290,000 ",Low income ,Asia ,Unknown ,,Bilateral ,2/24/2021,"162,667",Part of the 1M donation ,Source ,
40,7/1/2021,Portugal,High income,Equatorial Guinea ," 1,355,986 ",Upper middle income,Africa ,Unknown ,,Bilateral ,2/24/2021,"162,667",Part of the 1M donation ,Source ,
40,7/1/2021,Portugal,High income,Guinea-Bissau ," 1,920,922
 ",Low income ,Africa ,Unknown ,,Bilateral ,2/24/2021,"162,667",Part of the 1M donation ,Source ,
40,7/1/2021,Portugal,High income,Mozambique ,"30,366,036
",Low income ,Africa ,Unknown ,,Bilateral ,2/24/2021,"162,667",Part of the 1M donation ,Source ,
40,7/1/2021,Portugal,High income,São Tomé and Principe," 215,056
 ",Lower middle income,Africa ,Unknown ,,Bilateral ,2/24/2021,"162,667",Part of the 1M donation ,Source ,
40,6/28/2021,Portugal,High income,Cape Verde," 549,935 ",Lower middle income,Africa,Oxford-AstraZeneca _AZD1222,,Bilateral ,5/14/2021,"24,000",Part of the 1M donation ,Source ,
41,8/19/2021,Romania,High income,Ireland ," 4,941,444 ",High income ,Europe ,Unknown ,,Bilateral ,7/2/2021,"1,000,000",The Irish gov't purchased from Romania ,Source ,
41,6/22/2021,Romania,High income,Moldova," 2,657,637 ",Lower middle income,Europe,Unknown ,,Multilateral,2/18/2021,"200,000",,Source ,
42,6/24/2021,Russia,Upper middle income,Bosnia," 3,301,000 ",Upper middle income,Europe,Gamaleya Research Institute_Sputnik V,,Bilateral,2/12/2021,"5,000",,Source ,
42,6/24/2021,Russia,Upper middle income,Kyrgyzstan," 6,456,900 ",Lower middle income,Asia,Gamaleya Research Institute_Sputnik V,,Bilateral,4/22/2021,"500,000",,Source ,
42,6/24/2021,Russia,Upper middle income,Moldova," 2,657,637 ",Lower middle income,Europe,Gamaleya Research Institute_Sputnik V,,Bilateral,4/24/2021,"180,000",,Source ,
42,6/23/2021,Russia,Upper middle income,Georgia," 3,720,382 ",Upper middle income,Europe,Gamaleya Research Institute_Sputnik V,,Bilateral,2/3/2021,"20,000",,Source ,
42,6/22/2021,Russia,Upper middle income,Moldova," 2,657,637 ",Lower middle income,Europe,Gamaleya Research Institute_Sputnik V,,Bilateral ,4/1/2021,"180,000",,Source ,
42,6/16/2021,Russia,Upper middle income,Mongolia," 3,225,167 ",Lower middle income,Asia,Gamaleya Research Institute_Sputnik V,,Bilateral,4/27/2021,"300,000",,Source ,
42,6/16/2021,Russia,Upper middle income,Palestine," 4,685,306 ",Lower middle income,Asia,Gamaleya Research Institute_Sputnik V,,Bilateral,1/27/2021," 10,000 ",,Source ,
42,6/16/2021,Russia,Upper middle income,Vietnam," 96,462,106 ",Lower middle income,Asia,Gamaleya Research Institute_Sputnik V,,Bilateral,8/14/2020,Unknown ,,Source ,
43,6/28/2021,Saint Vincent,Upper middle income,Trinidad & Tobago," 1,394,973 ",High income ,South and Central America,Oxford-AstraZeneca _AZD1222,,,5/20/2021,"16,000",,Source ,
44,6/24/2021,Senegal,Lower middle income,Gambia ," 2,347,706 ",Low income,Africa,Sinopharm,,Bilateral,3/3/2021,"10,000",,Source,
45,6/24/2021,Serbia,Upper middle income,Bosnia ," 3,301,000 ",Upper middle income,Europe,Gamaleya Research Institute_Sputnik V,,Bilateral,3/2/2021,"10,000",,Source,
45,6/24/2021,Serbia,Upper middle income,Macedonia," 2,083,459 ",Upper middle income,Europe,Pfizer-BioNTech_BNT162,,Multilateral,2/14/2021,"8,000",,Source,
45,6/23/2021,Serbia,Upper middle income,Montenegro," 622,137 ",Upper middle income,Europe,Gamaleya Research Institute_Sputnik V,,Bilateral,unknown date,"2,000",,Source ,
45,6/22/2021,Serbia,Upper middle income,Macedonia," 2,083,459 ",Upper middle income,Europe,Gamaleya Research Institute_Sputnik V,,Bilateral,4/2/2021,"40,000",,Source ,
46,6/16/2021,South Africa,Upper middle income,Jamaica," 2,948,279 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,SII,Bilateral,4/9/2021,"75,000",,Source ,
47,10/1/2021,Spain,High income,COVAX ,Unknown ,COVAX/Other Global Entities,COVAX ,Unknown ,,COVAX ,9/22/2021,"30,000,000",,Source ,
47,8/26/2021,Spain,High income,Latin American Nations,,Upper middle income,South and Central America,Unknown,,Bilateral,8/7/2021,"7,500,000",,Source,
48,9/27/2021,Sweden,High income,COVAX , Unknown  ,COVAX/Other Global Entities,COVAX ,Oxford-AstraZeneca _AZD1222,AZ,COVAX,9/21/2021,"6,000,000",,Source,Source 
49,9/27/2021,Switzerland ,High income,COVAX , Unknown  ,COVAX/Other Global Entities,COVAX ,Oxford-AstraZeneca _AZD1222,,COVAX ,6/30/2021,"4,000,000",,Source ,
50,9/9/2021,Turkey,Upper middle income,Kyrgyzstan," 6,456,900 ",Lower middle income,Asia,Sinovac_Coronavac ,,Bilateral,9/9/2021,"150,000",,Source,
50,6/28/2021,Turkey,Upper middle income,Macedonia," 2,083,459 ",Upper middle income,Europe,Sinovac_Coronavac ,,Bilateral ,6/9/2021,"30,000",,Source ,
50,6/23/2021,Turkey,Upper middle income,Cyprus," 1,198,575 ",High income ,Europe,Sinovac_Coronavac ,,Bilateral,4/30/2021,"40,000",,Source ,
50,6/16/2021,Turkey,Upper middle income,Bosnia," 3,301,000 ",Upper middle income,Europe,Sinovac_Coronavac ,,Bilateral,4/17/2021,"40,000",,Source ,
50,6/16/2021,Turkey,Upper middle income,Libya," 6,777,452 ",Upper middle income,Africa,Sinovac_Coronavac ,,Bilateral,4/14/2021,"150,000",,Source ,
51,9/27/2021,United Arab Emirates,High income,Unknown ,Unknown ,Unknown ,Unknown ,Unknown ,,Bilateral ,5/10/2021,"24,781,750",,Source ,
51,9/27/2021,United Arab Emirates,High income,COVAX ,Unknown ,Unknown ,Unknown ,Unknown ,,COVAX ,5/10/2021,"1,000,000",,Source ,
51,6/24/2021,United Arab Emirates,High income,Seychelles," 97,625 ",Lower middle income,Africa,Unknown ,,Bilateral ,1/10/2021,"50,000",,Source ,
51,6/22/2021,United Arab Emirates,High income,Albania," 2,854,191 ",Upper middle income,Europe,Gamaleya Research Institute_Sputnik V,,Bilateral,3/23/2021,"10,000",,Source ,
51,6/22/2021,United Arab Emirates,High income,Egypt," 100,388,073 ",Lower middle income,Africa,Sinopharm,,Bilateral,12/11/2020,"50,000",,Source ,
51,6/22/2021,United Arab Emirates,High income,Libya," 6,777,452 ",Upper middle income,Africa,Gamaleya Research Institute_Sputnik V,,Bilateral,4/4/2021,"101,250",,Source ,
51,6/22/2021,United Arab Emirates,High income,Mauritania," 4,525,696 ",Lower middle income,Africa,Pfizer-BioNTech_BNT162,,Bilateral,3/27/2021,"5,000",,Source ,
51,6/22/2021,United Arab Emirates,High income,West Bank and Gaza," 4,685,306 ",Lower middle income,Asia,Gamaleya Research Institute_Sputnik V,,Bilateral,2/22/2021,"2,000",,Source,
52,7/1/2021,United Kingdom,High income,COVAX ,,COVAX/Other Global Entities,COVAX ,Oxford-AstraZeneca _AZD1222,,COVAX ,6/11/2021,"80,000,000",,Source,
52,7/1/2021,United Kingdom,High income,Unknown ,,low income ,Unknown ,Oxford-AstraZeneca _AZD1222,,Bilateral,6/11/2021,"20,000,000",,Source,
53,10/14/2021,United States,High income,Nigeria," 200,963,599 ",Lower middle income,Africa,Pfizer-BioNTech_BNT162,,COVAX ,10/12/2021,"3,577,860",,Source ,
53,10/7/2021,United States,High income,Egypt," 100,388,073 ",Lower middle income,Africa,Pfizer-BioNTech_BNT162,,COVAX ,10/1/2021,"1,600,000",,Source ,
53,10/7/2021,United States,High income,Mongolia," 3,225,167 ",Lower middle income,Asia,Pfizer-BioNTech_BNT162,,Bilateral & COVAX,10/5/2021,"900,000",,Source ,
53,9/30/2021,United States,High income,Lesotho," 2,125,268 ",Lower middle income,Africa,Janssen (J&J)_Ad26.COV2.S,,Bilateral ,7/23/2021,"302,400",,Source ,
53,9/30/2021,United States,High income,Liberia," 4,937,374 ",Low income,Africa,Janssen (J&J)_Ad26.COV2.S,,Bilateral ,7/25/2021,"302,400",,Source ,
53,9/30/2021,United States,High income,Madagascar," 26,969,307 ",Low income,Africa,Janssen (J&J)_Ad26.COV2.S,,Bilateral ,7/27/2021,"302,750",,Source ,
53,9/30/2021,United States,High income,Malaysia," 31,949,777 ",Upper middle income,Asia,Pfizer-BioNTech_BNT162,,Bilateral ,7/5/2021,"1,000,000",,Source ,
53,9/30/2021,United States,High income,Mozambique," 30,366,036 ",Low income,Africa,Janssen (J&J)_Ad26.COV2.S,,Bilateral ,7/26/2021,"302,400",,Source ,
53,9/30/2021,United States,High income,Nigeria," 200,963,599 ",Lower middle income,Africa,Moderna_mRNA-1273,,Bilateral ,8/2/2021,"4,000,000",,Source ,
53,9/30/2021,United States,High income,Panama," 4,246,439 ",Upper middle income,North America,Pfizer-BioNTech_BNT162,,Bilateral ,7/26/2021,"503,100",,Source ,
53,9/30/2021,United States,High income,Peru," 32,510,453 ",Upper middle income,South and Central America,Pfizer-BioNTech_BNT162,,Bilateral ,6/29/2021,"2,000,000",,Source ,
53,9/30/2021,United States,High income,Saint Lucia," 182,790 ",Upper middle income,North America,Pfizer-BioNTech_BNT162,,Bilateral ,8/18/2021,"52,560",,Source ,
53,9/30/2021,United States,High income,Saint Vincent and Grenadines," 110,589 ",Upper middle income,North America,Pfizer-BioNTech_BNT162,,Bilateral ,8/19/2021,"35,100",,Source ,
53,9/30/2021,United States,High income,South Africa," 58,558,270 ",Upper middle income,Africa,Pfizer-BioNTech_BNT162,,Bilateral ,7/28/2021,"5,700,000",,Source ,
53,9/30/2021,United States,High income,Suriname," 581,372 ",Upper middle income,South America,Pfizer-BioNTech_BNT162,,Bilateral ,8/20/2021,"140,400",,Source ,
53,9/30/2021,United States,High income,Taiwan,,,Asia,Moderna_mRNA-1273,,Bilateral ,6/19/2021,"2,500,000",,Source ,
53,9/30/2021,United States,High income,Thailand," 69,625,582 ",Upper middle income,Asia,Pfizer-BioNTech_BNT162,,Bilateral ,8/5/2021,"1,503,450",,Source ,
53,9/30/2021,United States,High income,Trinidad," 1,394,973 ",High income,South America,Pfizer-BioNTech_BNT162,,Bilateral ,8/11/2021,"305,370",,Source ,
53,9/23/2021,United States,High income,COVAX , Unknown ,Unknown,Unknown,Pfizer-BioNTech_BNT162,,COVAX ,9/22/2021,"500,000,000",,Source,
53,9/22/2021,United States,High income,Georgia," 3,720,382 ",Upper middle income,Europe,Pfizer-BioNTech_BNT162,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,9/22/2021,United States,High income,Guatemala," 16,604,026 ",Upper middle income,South and Central America,Moderna_mRNA-1273,,Bilateral,7/19/2021,"4,500,000",,Source ,
53,9/22/2021,United States,High income,Guyana," 782,766 ",Upper middle income,South and Central America,Pfizer-BioNTech_BNT162,,Bilateral ,8/24/2021,"146,250",,Source ,
53,9/22/2021,United States,High income,Jamaica," 2,948,279 ",Upper middle income,North America,Pfizer-BioNTech_BNT162,,Bilateral ,8/19/2021,"208,260",,Source ,
53,9/21/2021,United States,High income,Antigua," 97,118 ",High Income ,North America,Pfizer-BioNTech_BNT162,,Bilateral ,8/19/2021,"17,550",,Source ,
53,9/21/2021,United States,High income,Bahamas," 389,482 ",High income ,North America,Pfizer-BioNTech_BNT162,,Bilateral ,8/13/2021,"397,000",,Source ,
53,9/21/2021,United States,High income,Bangladesh," 163,046,161 ",Lower middle income,Asia,Moderna_mRNA-1273,,Bilateral ,7/19/2021,"5,500,000",,Source ,
53,9/21/2021,United States,High income,Barbados," 287,025 ",High income ,North America,Pfizer-BioNTech_BNT162,,Bilateral ,8/19/2021,"70,200",,Source ,
53,9/21/2021,United States,High income,Belize," 390,353 ",Lower middle income,North America,Pfizer-BioNTech_BNT162,,Bilateral ,8/18/2021,"345,150",,Source ,
53,9/21/2021,United States,High income,Bhutan," 763,092 ",Lower middle income,Asia,Moderna_mRNA-1273,,Bilateral ,7/12/2021,"500,000",,Source ,
53,9/21/2021,United States,High income,Bosnia," 3,301,000 ",Upper middle income,Europe,Pfizer-BioNTech_BNT162,,Bilateral ,6/24/2021,"500,000",Part of the 80M Donation,Source ,
53,9/21/2021,United States,High income,Colombia," 50,339,443 ",Upper middle income,South and Central America,Janssen (J&J)_Ad26.COV2.S,,Bilateral ,6/28/2021,"2,500,000",,Source ,
53,9/21/2021,United States,High income,Costa Rica," 5,047,561 ",Upper middle income,North America,Pfizer-BioNTech_BNT162,,Bilateral ,7/14/2021,"500,000",,Source ,
53,9/21/2021,United States,High income,Ecuador," 17,373,662 ",Upper middle income,South and Central America,Pfizer-BioNTech_BNT162,,Bilateral ,,"2,000,000",,Source ,
53,9/21/2021,United States,High income,El Salvador," 6,453,553 ",Lower middle income,North America,Moderna_mRNA-1273,,Bilateral ,7/4/2021,"1,500,000",,Source ,
53,9/21/2021,United States,High income,Eswatini," 1,148,130 ",Lower middle income,Africa,Janssen (J&J)_Ad26.COV2.S,,Bilateral,8/4/2021,"300,000",,Source ,
53,9/21/2021,United States,High income,Fiji," 889,953 ",Upper middle income,Oceania,Moderna_mRNA-1273,,Bilateral ,7/16/2021,"150,080",Part of the 80M donation,Source ,
53,9/16/2021,United States,High income,Afghanistan ," 38,041,754 ",Low income ,Asia ,Janssen (J&J)_Ad26.COV2.S,,Bilateral ,7/9/2021,"3,300,000",Part of the 80M donation ,Source ,Source 
53,9/1/2021,United States,High income,Sudan," 42,813,238 ",Low Income,Africa,Janssen (J&J)_Ad26.COV2.S,,Bilateral ,8/1/2021,"606,700",,Source ,
53,8/26/2021,United States,High income,Kenya," 52,573,973 ",Lower middle income,Africa,Moderna_mRNA-1273,,Bilateral,8/23/2021,"880,460",,Source,
53,7/29/2021,United States,High income,Colombia," 50,339,443 ",Upper middle income,South and Central America,Moderna_mRNA-1273,,Bilateral,7/23/2021,"3,500,000",,Source,
53,7/29/2021,United States,High income,Pakistan," 216,565,318 ",Lower middle income,Asia,Moderna_mRNA-1273,,Bilateral,7/23/2021,"3,000,000",,Source,
53,7/29/2021,United States,High income,Tajikistan," 9,321,018 ",Lower middle income,Asia,Moderna_mRNA-1273,,Bilateral,7/23/2021,"1,500,000",,Source,
53,7/29/2021,United States,High income,Vietnam," 96,462,106 ",Lower middle income,Asia,Moderna_mRNA-1273,,Bilateral,7/25/2021,"3,000,000",,Source,
53,7/22/2021,United States,High income,Argentina," 44,938,712 ",Upper middle income,South and Central America,Moderna_mRNA-1273,,Bilateral,7/16/2021,"3,500,000",,Source,
53,7/16/2021,United States,High income,African Union,,Low Income,Africa,Unknown ,,Bilateral,7/16/2021,"25,000,000",,Source,
53,7/9/2021,United States,High income,Paraguay," 7,044,636 ",Upper middle income,South and Central America,Pfizer-BioNTech_BNT162,,Bilateral,6/28/2021,"1,000,000",,Source,
53,7/8/2021,United States,High income,Pakistan," 216,565,318 ",Lower middle income,Asia,Moderna_mRNA-1273,,Bilateral,7/3/2021,"2,500,000",,Source,
53,6/30/2021,United States,High income,Honduras," 9,746,117 ",Lower middle income,North America,Moderna_mRNA-1273,,COVAX,6/28/2021,"1,500,000",,Source ,
53,6/28/2021,United States,High income,Brazil," 211,049,527 ",Upper middle income,South and Central America,Janssen (J&J)_Ad26.COV2.S,,COVAX,6/23/2021,"3,000,000",,Source ,
53,6/28/2021,United States,High income,Unknown ,,Unknown ,Unknown ,Unknown ,,Bilateral ,6/3/2021,"58,478,491",Part of the 80M donation that will be donated at a later date,Source ,
53,6/24/2021,United States,High income,Canada," 37,589,262 ",High income ,North America,Unknown ,,Bilateral,6/3/2021,"428,571",,Source ,
53,6/24/2021,United States,High income,Egypt," 100,388,073 ",Lower middle income,Africa,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/24/2021,United States,High income,Haiti," 11,263,077 ",Low income,North America,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/24/2021,United States,High income,India," 1,366,417,754 ",Lower middle income,Asia,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/24/2021,United States,High income,Iraq," 39,309,783 ",Upper middle income,Asia,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/24/2021,United States,High income,Jordan," 10,101,694 ",Upper middle income,Asia,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/24/2021,United States,High income,Kosovo," 1,794,248 ",Upper middle income,Europe,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/24/2021,United States,High income,South Korea," 51,709,098 ",High income ,Asia,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/24/2021,United States,High income,Ukraine," 44,385,155 ",Lower middle income,Europe,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/24/2021,United States,High income,UN Frontline Workers,,COVAX/Other Global Entities,International Organization ,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/24/2021,United States,High income,West Bank and Gaza," 4,685,306 ",Lower middle income,Asia,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/24/2021,United States,High income,Yemen," 29,161,922 ",Low income,Asia,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/23/2021,United States,High income,COVAX , Unknown  ,COVAX/Other Global Entities,COVAX ,Pfizer-BioNTech_BNT162,,COVAX,6/9/2021,"500,000,000",200M for 2021 & 300M for 2022 delivery,Source ,
53,6/16/2021,United States,High income,Africa,,Low income,Africa,Unknown ,,COVAX,6/3/2021,"5,000,000",Part of the 80M donation,Source ,
53,6/16/2021,United States,High income,Asia,,Upper middle income,Asia,Unknown ,,COVAX,6/3/2021,"7,000,000",Part of the 80M donation,Source ,
53,6/16/2021,United States,High income,Canada," 37,589,262 ",High income ,North America,Oxford-AstraZeneca _AZD1222,AZ,Bilateral,3/18/2021,"1,500,000",,Source,
53,6/16/2021,United States,High income,Mexico," 127,575,529 ",Upper middle income,North America,Oxford-AstraZeneca _AZD1222,AZ,Bilateral,3/18/2021,"2,500,000",,Source,
53,6/16/2021,United States,High income,Mexico," 127,575,529 ",Upper middle income,North America,Unknown ,,Bilateral,6/3/2021,"428,571",Part of the 80M donation,Source ,
53,6/16/2021,United States,High income,South and Central America,,Upper middle income,South and Central America,Unknown ,,COVAX,6/3/2021,"6,000,000",,Source ,
